This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Magellan Health (MGLN), Wellth Tie Up on Behavioral Change
by Zacks Equity Research
Magellan Health (MGLN) initiates a pilot program with Wellth to improve medication adherence and the general health of its members.
Molina Healthcare (MOH) Posts Q4 Loss, Misses on Revenues
by Zacks Equity Research
Molina Healthcare's (MOH) fourth-quarter results reflect escalating expenses.
What's in the Offing for Centene (CNC) This Earnings Season?
by Zacks Equity Research
Centene's (CNC) Q4 results are likely to reflect escalating costs and other COVID-related factors.
Earnings Preview: Molina (MOH) Q4 Earnings Expected to Decline
by Zacks Equity Research
Molina (MOH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
UnitedHealth (UNH) Enhances Virtual Care for Better Outcomes
by Zacks Equity Research
UnitedHealth (UNH) introduces virtual care offerings and expands services to boost telehealth visits.
Why Molina (MOH) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Molina (MOH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
4 HMO Stocks in Focus as Players Adapt to Changes in the Industry
by Zacks Equity Research
Changing political scenario, increased investments in technology, growing senior population carve a strong growth trajectory for players in the HMO industry.
Here's Why You Should Steer Clear of Centene (CNC) Stock Now
by Zacks Equity Research
Rising costs and poor financial leverage make Centene (CNC) an unattractive stock now.
Molina Healthcare (MOH) Acquires Magellan Health's Unit
by Zacks Equity Research
Molina Healthcare (MOH) wraps up the buyout of Magellan Health's arm MCC to expand its presence and boost its capabilities.
Centene (CNC) to Buy Magellan Health for Better Medical Care
by Zacks Equity Research
Centene (CNC) to acquire Magellan Health for providing better healthcare to the most susceptible and underserved communities.
Cigna (CI) Divests to Deepen Focus on Healthcare, Repay Debt
by Zacks Equity Research
Cigna's (CI) sale of its non-health unit paves way for it to focus on its core business and make debt repayments.
Molina Healthcare (MOH) Up 52.5% in a Year: More Room to Run?
by Zacks Equity Research
Molina Healthcare's (MOH) strategic initiatives augur well for its revenues, which in turn, might appreciate its stock price.
Here's Why Hold Strategy is Apt for Magellan (MGLN) Stock
by Zacks Equity Research
Magellan Health (MGLN) has been benefiting from persistent tie-ups for offering enhanced behavioral health solutions and prudent capital deployment measures.
Magellan Health (MGLN) Buys Bayless to Aid Behavioral Health
by Zacks Equity Research
Magellan Health (MGLN) purchases a majority stake in Bayless Integrated Healthcare to bolster/evolve its collaborative care strategy.
Centene (CNC) Announces Solid Financial Guidance for 2021
by Zacks Equity Research
Centene (CNC) provides an impressive 2021 guidance for key metrics owing to its strong inorganic growth story and a healthy revenue stream.
Centene (CNC) to Purchase Specialty Pharmacy PANTHERx Rare
by Zacks Equity Research
Centene (CNC) to buy specialty pharmacy PANTHERx Rare to penetrate the specialty drug market and cater to patients with complex situations.
3 Health Insurers That Crushed S&P YTD, Set to Rise Further
by Srijita Guha
We zero in on three health insurers that outperform the S&P Index YTD on the back of solid fundamentals. All these stocks hold prospects to continue the rally going forward.
Acadia Healthcare (ACHC) Forms JV to Boost Service in Detroit Area
by Zacks Equity Research
Acadia Healthcare (ACHC) partners with Henry Ford Health System for offering improved mental health services in Detroit and neighboring counties.
Ensign Group (ENSG) Bolsters Presence in Texas With Buyout
by Zacks Equity Research
Ensign Group (ENSG) acquires a skilled nursing facility in Texas, which further adds stimulus to the company's acquisition spree.
Is Molina Healthcare (MOH) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (MOH) Outperforming Other Medical Stocks This Year?
Is Molina Healthcare (MOH) a Worthy Pick for Value Investors?
by Zacks Equity Research
Let's see if Molina Healthcare (MOH) stock is a good choice for value-oriented investors right now from multiple angles.
Improving Patient Volumes Aid Select Medical's (SEM) Prospects
by Zacks Equity Research
Recovery in patient volumes owing to relaxation of government-imposed constraints is gradually restoring the patient admissions, thereby reinstating Select Medical (SEM) on the growth path.
Why You Should Add Molina Healthcare (MOH) to Your Portfolio
by Zacks Equity Research
Banking on strategic measures and growing revenues, Molina Healthcare (MOH) holds enough potential to reap benefits for investors.
Encompass Health (EHC) Continues to Bolster Presence in Ohio
by Zacks Equity Research
Encompass Health (EHC) continues to expand in Ohio via inauguration of the inpatient rehabilitation hospital in order to offer improved health services in the state.
Humana (HUM) to Offer MA Plans in Massachusetts for First Time
by Zacks Equity Research
Humana's (HUM) Medicare Advantage plans to make a debut in Massachusetts for fortifying the company's foothold in the state.